A foreign protein incorporated on the tip of T3 pili in Lactococcus lactis elicits systemic and mucosal immunity

Infection and Immunity

Volumn 78, Issue 3, 2010, Pages 1294-1303

  Quigley, Bernard R ^a   Hatkoff, Matthew ^b   Thanassi, David G ^b   Ouattara, Mahamoudou ^c   Eichenbaum, Zehava ^c   Scott, June R ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b STONY BROOK UNIVERSITY   (United States)

^c GEORGIA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; BACTERIAL VECTOR; CELL MEMBRANE PROTEIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; MALTOSE BINDING PROTEIN; PROTEIN CPA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BACTERIUM PILUS; CARBOXY TERMINAL SEQUENCE; IMMUNE RESPONSE; LACTOCOCCUS LACTIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; VACCINATION;

ANIMALS; ANTIBODIES, BACTERIAL; BACTERIAL VACCINES; BLOTTING, WESTERN; ESCHERICHIA COLI PROTEINS; FEMALE; FIMBRIAE, BACTERIAL; GENETIC VECTORS; HUMANS; IMMUNITY, HUMORAL; IMMUNITY, MUCOSAL; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; LACTOCOCCUS LACTIS; MICE; MICROSCOPY, IMMUNOELECTRON; PERIPLASMIC BINDING PROTEINS; RECOMBINANT FUSION PROTEINS; VACCINES, SYNTHETIC;

EID: 77349112664     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.01037-09     Document Type: Article

References (44)

1. Barnett, T. C., J. V. Bugrysheva, and J. R. Scott. 2007. Role of mRNA stability in growth phase regulation of gene expression in the group A streptococcus. J. Bacteriol. 189:1866-1873.
2. Barnett, T. C., A. R. Patel, and J. R. Scott. 2004. A novel sortase, SrtC2, from Streptococcus pyogenes anchors a surface protein containing a QVPTGV motif to the cell wall. J. Bacteriol. 186:5865-5875.
3. Baumann, U. 2008. Mucosal vaccination against bacterial respiratory infections. Expert Rev. Vaccines 7:1257-1276.
4. Biswas, I., P. Germon, K. McDade, and J. R. Scott. 2001. Generation and surface localization of intact M protein in Streptococcus pyogenes are dependent on sagA. Infect. Immun. 69:7029-7038.
5. Bolken, T. C., C. A. Franke, K. F. Jones, R. H. Bell, R. M. Swanson, D. S. King, V. A. Fischetti, and D. E. Hruby. 2002. Analysis of factors affecting surface expression and immunogenicity of recombinant proteins expressed by gram-positive commensal vectors. Infect. Immun. 70:2487-2491.
6. Bolotin, A., P. Wincker, S. Mauger, O. Jaillon, K. Malarme, J. Weissenbach, S. D. Ehrlich, and A. Sorokin. 2001. The complete genome sequence of the lactic acid bacterium Lactococcus lactis ssp. lactis IL1403. Genome Res. 11:731-753.
7. Buccato, S., D. Maione, C. D. Rinaudo, G. Volpini, A. R. Taddei, R. Rosini, J. L. Telford, G. Grandi, and I. Margarit. 2006. Use of Lactococcus lactis expressing pili from group B Streptococcus as a broad-coverage vaccine against streptococcal disease. J. Infect. Dis. 194:331-340.
8. Grangette, C., H. Muller-Alouf, D. Goudercourt, M. C. Geoffroy, M. Turneer, and A. Mercenier. 2001. Mucosal immune responses and protection against tetanus toxin after intranasal immunization with recombinant Lactobacillus plantarum. Infect. Immun. 69:1547-1553.
9. Grangette, C., H. Muller-Alouf, P. Hols, D. Goudercourt, J. Delcour, M. Turneer, and A. Mercenier. 2004. Enhanced mucosal delivery of antigen with cell wall mutants of lactic acid bacteria. Infect. Immun. 72:2731-2737.
10. Hallman, M., M. Ramet, and R. A. Ezekowitz. 2001. Toll-like receptors as sensors of pathogens. Pediatr. Res. 50:315-321.
11. Hanniffy, S. B., A. T. Carter, E. Hitchin, and J. M. Wells. 2007. Mucosal delivery of a pneumococcal vaccine using Lactococcus lactis affords protection against respiratory infection. J. Infect. Dis. 195:185-193.
12. Ho, S. N., H. D. Hunt, R. M. Horton, J. K. Pullen, and L. R. Pease. 1989. Site-directed mutagenesis by overlap extension using the polymerase chain reaction. Gene 77:51-59.
13. Holmgren, J., and C. Czerkinsky. 2005. Mucosal immunity and vaccines. Nat. Med. 11:S45-S53.
14. Holo, H., and I. F. Nes. 1989. High-frequency transformation, by electroporation, of Lactococcus lactis subsp. cremoris grown with glycine in osmotically stabilized media. Appl. Environ. Microbiol. 55:3119-3123.
15. Hutchings, A. B., A. Helander, K. J. Silvey, K. Chandran, W. T. Lucas, M. L. Nibert, and M. R. Neutra. 2004. Secretory immunoglobulin A antibodies against the sigma1 outer capsid protein of reovirus type 1 Lang prevent infection of mouse Peyer's patches. J. Virol. 78:947-957.
16. Johansson, E. L., L. Wassen, J. Holmgren, M. Jertborn, and A. Rudin. 2001. Nasal and vaginal vaccinations have differential effects on antibody responses in vaginal and cervical secretions in humans. Infect. Immun. 69:7481-7486.
17. Kang, H. J., F. Coulibaly, F. Clow, T. Proft, and E. N. Baker. 2007. Stabilizing isopeptide bonds revealed in gram-positive bacterial pilus structure. Science 318:1625-1628.
18. Kirschning, C. J., and R. R. Schumann. 2002. TLR2: cellular sensor for microbial and endogenous molecular patterns. Curr. Top. Microbiol. Immunol. 270:121-144.
19. Kratovac, Z., A. Manoharan, F. Luo, S. Lizano, and D. E. Bessen. 2007. Population genetics and linkage analysis of loci within the FCT region of Streptococcus pyogenes. J. Bacteriol. 189:1299-1310.
20. Lizano, S., F. Luo, and D. E. Bessen. 2007. Role of streptococcal T antigens in superficial skin infection. J. Bacteriol. 189:1426-1434.
21. Mandlik, A., A. Swierczynski, A. Das, and H. Ton-That. 2008. Pili in Gram-positive bacteria: assembly, involvement in colonization and biofilm development. Trends Microbiol. 16:33-40.
22. Mannam, P., K. F. Jones, and B. L. Geller. 2004. Mucosal vaccine made from live, recombinant Lactococcus lactis protects mice against pharyngeal infection with Streptococcus pyogenes. Infect. Immun. 72:3444-3450.
23. Medina, M., J. Villena, S. Salva, E. Vintini, P. Langella, and S. Alvarez. 2008. Nasal administration of Lactococcus lactis improves local and systemic immune responses against Streptococcus pneumoniae. Microbiol. Immunol. 52:399-409.
24. Medina, M., J. Villena, E. Vintini, E. M. Hebert, R. Raya, and S. Alvarez. 2008. Nasal immunization with Lactococcus lactis expressing the pneumococcal protective protein A induces protective immunity in mice. Infect. Immun. 76:2696-2705.
25. Muzio, M., N. Polentarutti, D. Bosisio, P. P. Manoj Kumar, and A. Mantovani. 2000. Toll-like receptor family and signaling pathway. Biochem. Soc. Trans. 28:563-566.
26. Nardelli-Haefliger, D., D. Wirthner, J. T. Schiller, D. R. Lowy, A. Hildesheim, F. Ponci, and P. De Grandi. 2003. Specific antibody levels at the cervix during the menstrual cycle of women vaccinated with human papillomavirus 16 virus-like particles. J. Natl. Cancer Inst. 95:1128-1137.
27. Neutra, M. R., and P. A. Kozlowski. 2006. Mucosal vaccines: the promise and the challenge. Nat. Rev. Immunol. 6:148-158.
28. Oliveira, M. L., A. P. Areas, I. B. Campos, V. Monedero, G. Perez-Martinez, E. N. Miyaji, L. C. Leite, K. A. Aires, and P. Lee Ho. 2006. Induction of systemic and mucosal immune response and decrease in Streptococcus pneumoniae colonization by nasal inoculation of mice with recombinant lactic acid bacteria expressing pneumococcal surface antigen A. Microbes Infect. 8:1016-1024.
29. Quigley, B. R., D. Zähner, M. Hatkoff, D. G. Thanassi, and J. R. Scott. 2009. Linkage of T3 and Cpa pilins in the Streptococcus pyogenes M3 pilus. Mol. Microbiol. 72:1379-1394.
30. Repa, A., C. Grangette, C. Daniel, R. Hochreiter, K. Hoffmann-Sommergruber, J. Thalhamer, D. Kraft, H. Breiteneder, A. Mercenier, and U. Wiedermann. 2003. Mucosal co-application of lactic acid bacteria and allergen induces counter-regulatory immune responses in a murine model of birch pollen allergy. Vaccine 22:87-95.
31. Ritter, K. 1991. Affinity purification of antibodies from sera using polyvinylidene difluoride (PVDF) membranes as coupling matrices for antigens presented by autoantibodies to triosephosphate isomerase. J. Immunol. Methods 137:209-215.
32. Robinson, K., L. M. Chamberlain, K. M. Schofield, J. M. Wells, and R. W. Le Page. 1997. Oral vaccination of mice against tetanus with recombinant Lactococcus lactis. Nat. Biotechnol. 15:653-657.
33. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning, a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY.
34. Scott, J. R. 1974. A turbid plaque-forming mutant of phage P1 that cannot lysogenize Escherichia coli. Virology 62:344-349.
35. Scott, J. R., and D. Zähner. 2006. Pili with strong attachments: Gram-positive bacteria do it differently. Mol. Microbiol. 62:320-330.
36. Spurlino, J. C., G. Y. Lu, and F. A. Quiocho. 1991. The 2.3-A resolution structure of the maltose- or maltodextrin-binding protein, a primary receptor of bacterial active transport and chemotaxis. J. Biol. Chem. 266:5202-5219.
37. Steidler, L., K. Robinson, L. Chamberlain, K. M. Schofield, E. Remaut, R. W. Le Page, and J. M. Wells. 1998. Mucosal delivery of murine interleukin-2 (IL-2) and IL-6 by recombinant strains of Lactococcus lactis coexpressing antigen and cytokine. Infect. Immun. 66:3183-3189.
38. Telford, J. L., M. A. Barocchi, I. Margarit, R. Rappuoli, and G. Grandi. 2006. Pili in gram-positive pathogens. Nat. Rev. Microbiol. 4:509-519.
39. Texereau, J., J. D. Chiche, W. Taylor, G. Choukroun, B. Comba, and J. P. Mira. 2005. The importance of Toll-like receptor 2 polymorphisms in severe infections. Clin. Infect. Dis. 41(Suppl. 7):S408-S415.
40. Villena, J., M. Medina, R. Raya, and S. Alvarez. 2008. Oral immunization with recombinant Lactococcus lactis confers protection against respiratory pneumococcal infection. Can. J. Microbiol. 54:845-853.
41. Villena, J., M. Medina, E. Vintini, and S. Alvarez. 2008. Stimulation of respiratory immunity by oral administration of Lactococcus lactis. Can. J. Microbiol. 54:630-638.
42. Wei, C. H., J. K. Liu, X. L. Hou, L. Y. Yu, J. S. Lee, and C. J. Kim. 2009. Immunogenicity and protective efficacy of orally or intranasally administered recombinant Lactobacillus casei expressing ETEC K99. Vaccine doi:10116/ j.vaccine. 2009.05.088.
43. Wells, J. M., and A. Mercenier. 2008. Mucosal delivery of therapeutic and prophylactic molecules using lactic acid bacteria. Nat. Rev. Microbiol. 6:349-362.
44. Zähner, D., and J. R. Scott. 2008. SipA is required for pilus formation in Streptococcus pyogenes serotype M3. J. Bacteriol. 190:527-535.